Comunicati.net - Comunicati pubblicati - Grand View Research Comunicati.net - Comunicati pubblicati - Grand View Research Fri, 05 Mar 2021 02:16:13 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/utenti/26632/1 Medical Device Analytical Testing Outsourcing Market Size To Hit USD 9.7 Billion By 2028 Wed, 03 Mar 2021 12:14:10 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/693060.html http://comunicati.net/comunicati/aziende/informatica/information_technology/693060.html Grand View Research Grand View Research San Francisco, 3 March 2021: The Report Medical Device Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Services, By Therapeutic Area (Cardiology, Diagnostic Imaging, Orthopedic), By End-use, By Device Type, By Region, And Segment Forecasts, 2021 - 2028

The global medical device analytical testing outsourcing market size is expected to reach USD 9.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.6% from 2021 to 2028. Numerous medical device companies outsource analytical testing operations to minimize business risks, hasten product market entry, and reduce costs. These procedures lead to a significant rise in expenditure levels and, therefore, original equipment manufacturers of medical instruments rapidly switch to outsourcing as one of the effective cost curbing tools.

Implantable Medical Devices (IMDs) are being used increasingly in order to improve patients’ health outcomes. Designers of IMDs have to balance complexity, reliability, power consumption, and costs. Consequently, companies are shifting their focus to innovation rather than non-core activities and, therefore, outsourcing these activities to launch efficient instruments. All these factors are expected to drive the market over the forecast period.

In this complex ecosystem, it is necessary for the equipment to provide accurate results, to have durability, and easy operation. To match these parameters, devices now have to undergo shear checking in accelerated conditions to obtain marketing approval and have a competitive advantage. Conducting this in-house is a matter of time, labor, and cost; outsourcing these tests helps overcome these limitations. For instance, the ISO 10993 has revised the Analytical Evaluation Threshold (AET) for better toxicological safety assessment. Lack of awareness with regards to these tests among the manufacturers of medical instruments may lead to reworking, which is usually avoided when outsourced to third-parties. Hence it is very important to be aware of AET as regulators will review the analytical report to check whether the AET was followed or not. Also, it is the duty of the medical device manufacturer to ensure that AET is applied to the checking process.

Various companies globally have increased the manufacturing of medical devices such as personal protective equipment (PPE) kits, ventilators, and N-95 masks. This has created opportunities for the players in the Testing, Inspection, and Certification (TIC) Market to test and certify these instruments. Many companies such as TÜV SÜD and Eurofins have started checking these medical instruments, thus increasing the demand for analytical testing services from the healthcare industry. Also with increasing cases of COVID-19 globally, the demand for analytical testing services will surge in the coming months.

Access Research Report of Medical Device Analytical Testing Outsourcing Market https://www.grandviewresearch.com/industry-analysis/medical-device-analytical-testing-outsourcing-market

Medical Device Analytical Testing Outsourcing Market Report Highlights

  • The material characterization segment dominated the market in 2020 and is likely to grow at a lucrative rate during the forecast period
  • Other tests that are inclusive of cleaning, reprocessing, method development and validation, accelerated stability testing, biocompatibility, validation checking for packaging materials (container closure permeation), and transport stability are anticipated to witness the fastest growth over the forecast period
  • North America accounted for significant market share owing to the fact that it is one of the top manufacturing hubs of highly reliable, complex, and high-end medical instruments, with the presence of abundant service providers

List of Key Players of Medical Device Analytical Testing Outsourcing Market

  • SGS SA
  • Toxikon, Inc.
  • Eurofins Scientific
  • Pace Analytical Services, LLC
  • Intertek Group plc
  • WuXi AppTec.
  • NORTH AMERICAN SCIENCE ASSOCIATES INC.
  • Envigo
  • Charles River Laboratories International Inc.
  • Medical Device Testing Services

Access Press Release of Medical Device Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-medical-device-analytical-testing-outsourcing-market

 

]]>
Pharmaceutical Analytical Testing Outsourcing Market Latest Report By Service ,Region And Forecast To 2028 Wed, 03 Mar 2021 11:53:32 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/693050.html http://comunicati.net/comunicati/aziende/informatica/information_technology/693050.html Grand View Research Grand View Research San Francisco, 3 March 2021: The Report Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability Testing), By Region (North America, APAC), And Segment Forecasts, 2021 - 2028

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 12.4 billion by 2028 registering a CAGR of 8.3%, according to a new report by Grand View Research, Inc. Increasing pipelines for biological candidates along with rising demand for additional analytical details on drugs as well as process development by regulatory agencies are boosting the market growth. Analytical testing helps in providing real-time product quality control along with optimizing & monitoring processes, characterize biosimilar & biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to access skilled & experienced expertise, as well as expensive analytical equipment not available in-house.

Increasing R&D investments is one of the critical sustainability strategies. Not all companies have an infrastructure that is compatible with all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and cost. A patent cliff largely for small molecules with the pharmaceutical industry has led to a huge dent in the pharma’s profits. In the coming years, several best-selling drugs are coming towards the end of patent life including Humira. Drug innovators are under constant pressure to launch new products. Developing advanced analytical testing to assess & monitor the quality attributes of these requires a broader set of equipment & expertise, which is beyond the internal capacity of pharma companies.

The market is developing due to increasing competition in the pharmaceutical and biopharmaceutical markets for disease-specific drugs. Most pharmaceutical manufacturing companies rely on analytical testing to help and improve productivity, optimize and monitor processes, and offer real-time product quality control. Due to this, there is an increasing demand for analytical testing outsourcing services. Hence the market is expected to show lucrative growth over the forecast period. Outsourcing of analytical testing services allows companies to handle more complex activities and focus on their core competencies. This offers cost savings by letting medical companies evade building specialized facilities and hiring staff. Pharmaceutical analytical testing includes the identification and quantification of components in therapeutic solutions or drugs.

The nature of Covid-19 transmission has led several laboratory staff members to face uncertainties, such as fears of contracting the infection along with other biosafety concerns. Thus, reduced manpower and increasing focus on the development of vaccines & therapies against Covid-19 are anticipated to negatively impact the turnaround time for routine tests. The large number of R&D activities, clinical trials, and diagnostic procedures being conducted to counteract Covid-19 is anticipated to increase the demand for analytical testing services since several pharmaceutical companies are now focusing on their core competencies and outsourcing non-core functions to increase their productivity & operational efficiency.

Access Research Report of Pharmaceutical Analytical Testing Outsourcing Market https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights

  • The bioanalytical testing segment led the global market in 2020 accounting for the largest revenue share due to the high number of clinical trial registrations and entry of new participants within the market space
  • The segment is also expected to register the fastest CAGR over the forecast period owing to growing R&D expenditure by pharmaceutical companies and preference for outsourcing bioanalytical testing
  • The extractable and leachable services in the method development and validation segment is expected to dominate the market and register the fastest CAGR owing to an increasing number of vendors offering these services at competitive prices
  • Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 due to low-cost service offering by the third-party service providers in the region

List of Key Players of Pharmaceutical Analytical Testing Outsourcing Market

  • SGS SA
  • Toxikon, Inc.
  • Eurofins Scientific
  • Pace Analytical Services, Inc.
  • Intertek Group Plc
  • Pharmaceutical Product Development, LLC.
  • WuXi AppTec, Inc.
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • West Pharmaceutical Services Inc.

Access Press Release of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-analytical-testing-outsourcing-market

 

]]>
Biotechnology & Pharmaceutical Services Outsourcing Market Demand By Service, End-Use, Region And Forecast 2028 Wed, 03 Mar 2021 09:08:48 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692988.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692988.html Grand View Research Grand View Research San Francisco, 3 March 2021: The Report Biotechnology & Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End-use (Pharma, Biotech), And Segment Forecasts, 2021 - 2028

The global biotechnology and pharmaceutical services outsourcing market size is expected to reach USD 91.4 billion by 2028 registering a CAGR of 5.2%, according to a new report by Grand View Research, Inc. The high demand for biologics along with small molecules has led to the expansion of service portfolios of Contract Manufacturing Organizations (CMOs)/Contract Research Organizations (CROs) for biotechnology and pharmaceutical production. Small pharma/biotech companies are facing challenges while performing in-house development, regulatory affairs, product maintenance, product design & development, product testing & validation, and training & education, such as lack of substantial expertise and expensive capability. This, in turn, has created lucrative opportunities for the growth of CMOs & CROs. Contract services are growing and becoming strategic, targeted, and planned. These factors are expected to play a pivotal role in enhancing the share of CMOs/CROs in the overall market.

Growing pricing pressure, regulatory challenges, and patent expiration have led to shrinking margins in the biotech and pharmaceutical industry. Contract services offer cost saving to their clients and also help save time utilized in operations and management of a production & research facility. Furthermore, outsourcing services assist in overcoming trade barriers and facilitate the entry of firms into foreign markets. Owing to these advantages, several firms choose to outsource services rather than investing capital in production equipment and hiring skilled labor.

The coronavirus outbreak is having a considerable impact on biotech and pharma third-party service providers as well as clinical trials, resulting in trial delays, suspensions, and terminations. The global crisis has emphasized the need for virtual trials and leveraging on technology & software solutions. Increasing adoption of machine learning-based platforms & Artificial Intelligence (AI), innovative trial designs, and automation in drug manufacturing are projected to transform the CRO and CMO landscape in the coming years. Biopharmaceutical & pharmaceutical investments in novel and innovative therapies, for instance, regenerative medicine, are driving the R&D activity together with drug development services.

The biologics industry has grown substantially in recent years to include novel product types including nanobodies, rDNA, synthetic vaccines, fusion proteins, soluble receptors, immunoconjugates, and immunotherapeutics. Owing to the revolutionization of disease therapy through biologics, this sector has also provided many opportunities to explore hybrid structures that combine biologics with well-defined chemical entities. The significant growth of biologics is expected to drive the demand for outsourcing of biologics development and manufacturing.

Access Research Report of Biotechnology & Pharmaceutical Services Outsourcing Market https://www.grandviewresearch.com/industry-analysis/biotechnology-pharmaceutical-services-outsourcing-market

Biotechnology & Pharmaceutical Services Outsourcing Market Report Highlights

  • The consulting service segment led the market in 2020 and will retain its dominant position throughout the forecast period
  • Biotechnology and pharmaceutical companies are increasingly opting for consulting services due to factors, such as the increasing number of fraudulent cases and discrepancies in intellectual property rights
  • The pharma end-use segment is expected to lead the market in terms of revenue share as well as CAGR over the forecast period as the pharma companies outsource internal activities at a larger scale due to rising pricing pressure and increasing competition
  • North America was the dominant regional market in 2020 due to the presence of biotechnology and pharmaceutical companies and the high quality of services offered by the CROs and CMOs in the region
  • However, Asia Pacific is anticipated to register the fastest CAGR over the forecast period owing to improved regulatory frameworks, the high scope for cost savings, availability of cheap labor & skilled personnel, and rapid growth of the biotechnology and pharmaceutical industry in the region

List of Key Players of Biotechnology & Pharmaceutical Services Outsourcing Market

  • The Quantic Group
  • IQVIA
  • Parexel International Corp.
  • Lachman Consultant Services, Inc.
  • GMP Pharmaceuticals Pty Ltd.
  • Concept Heidelberg GmbH
  • Covance, Inc.
  • Charles River Laboratories
  • PRA Health Sciences
  • ICON plc

 Access Press Release of Biotechnology & Pharmaceutical Services Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-biotechnology-pharmaceutical-services-outsourcing-market

 

]]>
Contrast Media Market Demand By Product Type, Modality, Application, Region And Forecast To 2028 Wed, 03 Mar 2021 08:47:36 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692980.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692980.html Grand View Research Grand View Research San Francisco, 3 March 2021: The Report Contrast Media Market Size, Share & Trends Analysis Report By Product Type (Iodinated, Gadolinium-based, Barium-based), By Application, By Modality (MRI, X-ray/CT, Ultrasound), By Region, And Segment Forecasts, 2021 - 2028

The global contrast media market size is expected to reach USD 7.2 billion by 2028, according to a new report published by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2021 to 2028. The increasing burden of chronic diseases is driving the demand for diagnostic imaging procedures which are anticipated to fuel market growth.

The imaging tests such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and X-rays have become an inevitable part of the diagnosis for most diseases. The large-scale penetration of imaging technology in healthcare has increased the demand for chemical agents.

The introduction of artificial intelligence in radiology has improved image reconstruction and enabled the quantification of noninvasive imaging biomarkers. Such developments are anticipated to significantly affect the demand for the chemical agents. For instance, research conducted by Stanford University demonstrated that the use of artificial intelligence-based image reconstruction can reduce and/or eliminate the need for Gadolinium-based Contrast Agents (GBCAs).

Diagnostic imaging modalities are being increasingly used owing to advancements in the underlying technology, ranging from equipment to administration technology. Innovative products, such as syringeless injectors and innovative packaging, help achieve greater accuracy in delivering the right dose of contrast agents as well as reduce wastage. For instance, in August 2020, the U.S. FDA approved the Gadavist Imaging Bulk Package with transfer spike, thus enabling weight-based and multi-patient dosing as well as addressing the issues faced by hospitals related to vial waste. The approval of such innovative packaging is anticipated to increase the demand for the chemical agent.

Access Research Report of Contrast Media Market https://www.grandviewresearch.com/industry-analysis/contrast-media-contrast-agents-market

Contrast Media Market Report Highlights

  • Iodinated contrast media was the largest segment in 2020 and is anticipated to remain dominant over the forecast period as the products have excellent radio-opacity and low toxicity
  • X-ray/ CT was the largest modality segment in 2020, in terms of revenue share, owing to wide acceptance and cost-efficiency of the techniques
  • Cardiovascular diseases are projected to witness the fastest growth over the forecast period due to label extensions for ultrasound and X-ray/CT contrast agents in the U.S.
  • North America dominated the market and accounted for the largest revenue share of more than 40.0% in 2020 owing to the presence of well-established healthcare infrastructure and availability of advanced technology

List of Key Players of Contrast Media Market

  • Bayer AG
  • General Electric Company
  • Guerbet
  • Bracco Diagnostic, Inc.
  • Nano Therapeutics Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • iMax
  • Trivitron Healthcare

 Access Press Release of Contrast Media Market @ https://www.grandviewresearch.com/press-release/global-contrast-media-contrast-agents-market

 

]]>
Blood Glucose Monitoring Devices Market Overview By Product, End-Use, Region And Forecast To 2028 Wed, 03 Mar 2021 08:26:56 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692972.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692972.html Grand View Research Grand View Research San Francisco, 6 Jan 2021: The Report Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-monitoring, Continuous), By End-use (Hospitals, Home Care, Diagnostic Centers), By Region, And Segment Forecasts, 2021 - 2028

The global blood glucose monitoring devices market size is expected to reach 19.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.6% from 2021 to 2028. The market growth is propelled by the rising diabetes prevalence worldwide and increasing geriatric population. Moreover, rising awareness about diabetes preventive care and new product launches are expected to boost market growth.

Blood glucose monitoring (BGM) devices are used to measure blood glucose levels in diabetes patients. These devices help in analyzing glucose level pattern as it provides continuous and real-time blood sugar reading. It also helps patients to decide the amount of food intake and dosage of insulin. Furthermore, factors such as sedentary lifestyle, consumption of junk food and alcohol, smoking, and surge in the need for safer and faster diagnosis are propelling the market growth.

Obesity is also one of the major factors in propelling the prevalence of diabetes. According to the WHO, over 650 million people were obese in 2016 and this number is expected to grow further during the forecast period. Additionally, the market is expected to witness a high growth rate during the forecast period due to the continuous efforts for diabetes control by government and healthcare organizations, such as the International Diabetes Federation (IDF). Such organizations provide the required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Moreover, increasing health care funding is anticipated to propel the market growth.

Access Research Report of Blood Glucose Monitoring Devices Market https://www.grandviewresearch.com/industry-analysis/blood-glucose-monitoring-bgm-devices-market

Blood Glucose Monitoring Devices Market Report Highlights

  • North America held the largest market share in 2020 owing to favorable reimbursement policies, local presence of key players, and supportive government initiatives
  • Based on product, the self-monitoring devices segment held the largest market share in 2020 and is expected to grow at a significant pace over the forecast period. The testing strips segment of self-monitoring devices held the largest share of more than 40.0% in 2020 and is projected to grow at a healthy CAGR over the forecast period
  • The continuous blood glucose monitoring devices segment is expected to be the fastest-growing segment during the forecast period
  • By end-use, the home care segment is expected to grow at a rapid pace during the forecast period

List of Key Players of Blood Glucose Monitoring Devices Market

  • Abbott Laboratories
  • Medtronic plc
  • Hoffmann-La Roche Ltd.
  • Bayer AG
  • Lifescan, Inc.
  • Dexcom, Inc.
  • Sanofi
  • Elly Lilly and Company
  • B Braun Melsungen AG

Access Press Release of Blood Glucose Monitoring Devices Market @ https://www.grandviewresearch.com/press-release/global-blood-glucose-monitoring-devices-market

 

]]>
Dental X-ray Market Latest Trends On The Basis Of Product, Type, Application, Region And Forecast To 2028 Wed, 03 Mar 2021 08:08:14 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692962.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692962.html Grand View Research Grand View Research dental-x-ray

San Francisco, 3 March 2021: The Report Dental X-ray Market Size, Share & Trends Analysis Report By Product (Analog, Digital), By Type (Intraoral, Extraoral), By Application (Medical, Cosmetic Dentistry, Forensic), By Region, And Segment Forecasts, 2021 - 2028

The global dental x-ray market size is expected to reach USD 3.35 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 18.6% from 2021 to 2028. The increasing prevalence of oral diseases as well rising geriatric population are some of the factors that have led to the growth of the market.

Dental x-ray systems are useful in detecting and recording areas of decay that are undetectable by oral examination, especially minor areas of decay present between teeth. The rising prevalence of periodontitis is also accelerating the demand for these instruments. According to the CDC, 47.2% of adults aged 30 years in the U.S. have some form of periodontal disease with the condition being more common in men than women as they are more prone to smoking and health conditions, like diabetes. Other oral diseases contributing to the high demand for dental x-ray units are oral infections, gum diseases, oral cavities, periodontitis, tooth decay, and tumor or cyst detection. Early diagnosis of severe dental problems helps in treating them at the nascent stage, thus leading to potential cost savings.

The geriatric population plays a significant role in the growth of the market. This group of population is highly susceptible to various kinds of oral problems, thus considered to be a lucrative target population for the market. Furthermore, major companies are undertaking initiatives such as new product development. For instance, in 2019, Dentsply Sirona introduced Orthophos Systems 2D/3D extraoral imaging system that allows the practitioners to image, diagnose, and treat (IDT) for higher case acceptance and expand their treatment procedures into implantology, endodontics, etc.

Access Research Report of Dental X-ray Market https://www.grandviewresearch.com/industry-analysis/dental-x-ray-market

Dental X-ray Market Report Highlights

  • By product, analog radiographs held the largest market share in 2020 as they are easier to use as compared to digital systems. Digital radiography is anticipated to grow at a significant rate over the forecast period as it is an environmentally friendly technology, requiring no film or chemicals and generating no waste
  • Based on type, intraoral x-ray imaging held the largest share in 2020 as it is the most widely used diagnostic method in the field of dentistry. Extraoral imaging is anticipated to register the highest CAGR over the forecast period due to the rising incidence of temporomandibular disorders
  • The medical application segment held the largest share in 2020 due to its increasing use in the diagnosis and treatment of diseases of the oral cavity, which includes gums, bone, teeth, and other oral tissues
  • In North America, the U.S. held the largest revenue share in 2020 as the country is witnessing a gradual shift toward the incorporation of digital imaging systems
  • Asia Pacific is expected to be the fastest-growing regional market over the forecast period owing to the presence of densely populated countries, such as China and India

List of Key Players of Dental X-ray Market

  • Dentsply Sirona Inc.
  • Planmeca OY
  • Carestream Dental, LLC
  • Danaher
  • LED Medical Diagnostics, Inc.
  • Cefla S.C.
  • Vatech Co., Ltd.
  • Yoshida Dental Mfg. Co. Ltd.

Access Press Release of Dental X-ray Market @ https://www.grandviewresearch.com/press-release/global-dental-x-ray-market

 

]]>
Bone Graft And Substitutes Market Scope By Material Type, Application, Region And Forecast To 2028 Wed, 03 Mar 2021 07:44:47 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692954.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692954.html Grand View Research Grand View Research San Francisco, 3 March 2021: The Report Bone Graft And Substitutes Market Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Dental, Foot & Ankle), By Region, And Segment Forecasts, 2021 - 2028

The global bone graft and substitutes market size is expected to reach USD 4.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.8% from 2021 to 2028. The synthetic segment is anticipated to show significant growth over the forecast period. This growth is due to the lesser risk of disease transmission, better acceptance among patients as compared to allografts, and products’ better biocompatibility. However, the demand for orthopedic devices, which include bone graft and substitutes observed a radical decrease because of the rescheduling of elective surgeries during COVID-19.

Growing cases of spinal deformities are the key driver of this market. According to a CDC report, approximately 60.0% of the aged population and 32.0% of the adult population is suffering from spinal deformities, in the U.S., as of 2017. Around 488,000 spinal procedures were performed in the U.S. Moreover, the introduction of biocompatible synthetic grafts is also expected to drive the market.

Additionally, technological advancements and the growing geriatric population are also boosting the market growth. According to Population Reference Bureau’s 2018 statistics, from 13 countries to around 82 countries across the globe are expected to have more than 20% of the geriatric population (65 years and above) by 2050. Thus, perpetual growth in the population aged 60 years and above is anticipated to result in an increased prevalence of arthritis and joint disorders.

The market in various countries is expected to witness diverse trends because of ethical issues in some of the Muslim and Jewish population dominated countries. These countries include majorly the Middle Eastern countries, which are apprehensive about using xenografts for their orthopedic surgeries. Such factors hamper market growth drastically.

Key players in the market are investing in the launch of new products and product approvals for sustaining in the market. For instance, AlloSource stated that ProChondrix CR would have 2 years of shelf life based on the results of real-time testing, as of March 2019. ProChondrix CR helps in cartilage healing and is intended to match biochemical and biomechanical properties of normal hyaline cartilage, improve patient symptoms, and restore a smooth articular cartilage surface.

Access Research Report of Bone Graft And Substitutes Market https://www.grandviewresearch.com/industry-analysis/bone-grafts-substitutes-market

Bone Graft And Substitutes Market Report Highlights

  • The allograft segment dominated the market in terms of revenue share as of 2020 and is projected to witness a CAGR of over 4.8% from 2021 to 2028. Adoption of allografts is rising due to their characteristics such as osteoconductivity and immediate structural support.
  • North America held a major market share as of 2020, due to the growing awareness related to the commercially available advanced products, higher healthcare expenditure of 16.4% in 2018, and accessibility of a well-developed healthcare structure
  • The synthetic segment which includes ceramics, composites, polymers, and BMPs is expected to exhibit the fastest growth over the forecast period owing to its increasing adoption
  • The spinal fusion segment held a considerable revenue share of about 60.5% in the market in 2020 owing to the rising geriatric population
  • In North America, the U.S. is generating the maximum demand for bone grafts and substitutes because of the high prevalence of trauma-related injuries and orthopedic diseases
  • The industry participants are focusing on product launch, partnership, and acquisitions to sustain the competition
  • In Asia Pacific, the market is anticipated to witness lucrative growth of more than 7.5% owing to the rising medical tourism and favorable government initiatives

List of Key Players of Bone Graft & Substitutes Market

  • AlloSource
  • Baxter
  • DePuy Synthes, Inc.
  • Medtronic
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
  • Smith & Nephew, Inc.
  • Stryker Corporation
  • Wright Medical Group N.V.
  • OST Devloppement
  • Zimmer Biomet
  • Geistlich Pharma AG
  • TBF Tissue Engineering
  • Biobank

Access Press Release of Bone Graft And Substitutes Market @ https://www.grandviewresearch.com/press-release/global-bone-grafts-substitutes-market

 

]]>
Intravenous Solutions Market Outlook By Type, Nutrients, Region And Forecast Till 2028 Wed, 03 Mar 2021 07:13:55 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692931.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692931.html Grand View Research Grand View Research San Francisco, 3 March 2021: The Report Intravenous Solutions Market Size, Share & Trends Analysis Report By Type (TPN, PPN), By Nutrients (Carbohydrates, Single Dose Amino Acid Solution, Parenteral Lipid Emulsion), By Region, And Segment Forecasts, 2021 - 2028

The global intravenous solutions market size is expected to reach USD 18.9 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market.

One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. According to the WHO, in 2017, diarrhea was the second leading cause of death in children under 5 years of age with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a key role in the treatment and prevention of deaths caused due to the dehydration/fluid loss associated with diarrhea. Other cases where intravenous fluids find application include surgeries and emergency situations.

The ongoing COVID-19 pandemic is expected to have a positive impact on the market. Intensive Care Units (ICU) worldwide are either operating at full capacity or are overcrowded due to the high influx of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As per an article published by BBC, in January 2021, critical care wards across England were running in full capacity. Nutritional care is one of the essential elements in managing these patients. This has increased the demand for intravenous (IV) fluids, as many of the patients, especially the elderly population are placed on ventilators and are unable to consume food orally.

Access Research Report of Intravenous Solutions Market https://www.grandviewresearch.com/industry-analysis/intravenous-iv-solutions-market

IV Solutions Market Report Highlights

  • The Total Parenteral Nutrition (TPN) segment led the segment in terms of revenue share in 2020 owing to its growing applications in the management of chronic diseases
  • The increasing number of surgeries and post-operative nutritional management is a prime factor driving the vitamins and minerals (salt and electrolyte) segment’s growth
  • North America dominated the market with a revenue share of nearly 40.8% in 2020 due to the high usage of IV fluids in the U.S.

List of Key Players of IV Solutions Market

  • Hospira
  • Terumo Corporation
  • Braun Melsungen AG
  • Fresenius Kabi
  • Baxter

Access Press Release of Intravenous Solutions Market @ https://www.grandviewresearch.com/press-release/global-intravenous-iv-solutions-market

 

]]>
3D Cell Culture Market Demand By Technology, Application, End Use, Region And Forecast To 2028 Tue, 02 Mar 2021 11:19:38 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692699.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692699.html Grand View Research Grand View Research San Francisco, 29 Jan 2021: The Report 3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold-free, Scaffold-based), By Application (Cancer, Stem Cell Research), By End Use, By Region, And Segment Forecasts, 2021 - 2028

The global 3D cell culture market size is expected to reach USD 3.48 billion by 2028 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. The development of 3D optimized assays, kits, and protocols coupled with the evolution of assay techniques is anticipated to drive the three-dimensional cell culture market.

As 3-dimensional cultures have the capacity to closely mimic a typical morphology and microarchitecture of organs, these are continuously developed for the studies that require in vivo model systems to analyze the effect of a foreign drug over body tissues and organs. This, coupled with the availability of various choices in terms of material and structure of the scaffold for different in vitro applications, is anticipated to support revenue generation for scaffolds.

Recent researches have explored the use of a diverse range of scaffolds including graphene scaffolds, nanofibers, freeze-casting, natural marine collagen, and others. In addition, the application of lab-on-a-chip techniques in several assay types-proliferation, viability, stimulation, transport, patch clamping, high content screening, and metabolic activity-leads to a rise in demand for projects with advanced and efficient solutions.

Access Research Report of 3D Cell Culture Market https://www.grandviewresearch.com/industry-analysis/3d-cell-culture-market

3D Cell Culture Market Report Highlights

  • The scaffold-based technology segment is anticipated to register a lucrative year-on-year growth owing to rising demand for 3D model-based research coupled with an increased incidence of chronic diseases
  • Moreover, the introduction of novel tools and techniques is anticipated to boost revenue generation in the scaffold-based technology segment
  • Furthermore, companies, such as Tecan and Sigma-Aldrich, offer scaffold-based 3D solutions; which are readily adopted by the end users
  • Cancer was the largest application segment of the market in 2020. This is because 3D cultures efficiently replicate the associated influences and complexity of in vivo tumor microenvironment including the impact of extracellular matrix and cell-to-cell contact
  • Cells in 3-dimensional cultures help in the analysis of behavior and properties of the tumor, protein distribution, gene expression, and monitor response to anticancer therapies
  • Potential scientific and clinical impacts of the 3D-cultivation approach for embryonic, adult, and cancer stem cells are estimated to boost the growth of the stem cell research segment
  • Biotechnology and pharmaceutical organizations accounted for the largest share in 2020 owing to a rise in the adoption of 3D cell culture techniques in tissue engineering and drug discovery
  • Combination of 3D cell culture techniques with Human-induced Pluripotent Stem Cells (HiPSCs) has been successfully used for the development and discovery of drugs for liver diseases
  • North America led the market in 2020 owing to extensive usage of 3D cell culture models for medical research purposes
  • In April 2020, a team of researchers from the University of Pittsburgh used Multicellular Tumor Spheroids (MCTSs) to assess drug responses in drug screening studies for oncology
  • Asia Pacific is expected to register the fastest CAGR from 2021 to 2028 due to rising investments by North American and European companies in APAC regional market
  • The key market players focus on geographical expansions, partnerships, collaborations, acquisitions, and novel product launches to reinforce their market presence
  • For instance, in December 2020, Curiteva, Inc. acquired FossiLabs, LLC. The latter has developed a process to fabricate scaffolding structures that promote osseointegration

List of Key Players of 3D Cell Culture Market

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • PromoCell GmbH
  • Greiner Bio One International GmbH
  • Corning, Inc.
  • 3D Biomatrix
  • Lonza
  • Avantor Performance Materials, LLC
  • Tecan Trading AG
  • 3D Biotek LLC
  • Global Cell Solutions, Inc.
  • InSphero

Access Press Release of 3D Cell Culture Market @ https://www.grandviewresearch.com/press-release/global-3d-cell-culture-market 

]]>
Antiseptics And Disinfectants Market Overview By Type, Product, End Use, Sales Channel, Region And Forecast Till 2028 Tue, 02 Mar 2021 09:20:32 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692641.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692641.html Grand View Research Grand View Research San Francisco, 2 March 2021: The Report Antiseptics And Disinfectants Market Size, Share & Trends Analysis Report By Type, By Product, By End Use (Hospitals, Clinics), By Sales Channel (FMCG, B2B), By Region, And Segment Forecasts, 2021 - 2028

The global antiseptics and disinfectants market size is expected to reach USD 105.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 20.8% from 2021 to 2028. Increasing use of endoscope reprocessors and surgical units, and rising prevalence of hospital-acquired infections are the key driving factors for the market.

Increasing cases of HAIs due to lack of sanitation and precaution is a key factor anticipated to propel the market growth over the forecast period. According to the CDC report in 2018, around 1.7 million cases of HAIs and around 99,000 associated deaths are reported each year in American hospitals. As per the report published by European Centre for Disease Prevention and Control (ECDC) in 2018, prevalence of HAIs in European countries was around 7.1%. It also reported that around 4,131,000 patients suffer from HAIs in Europe each year.

Such cases are expected to increase the demand for antiseptics and disinfectants. Application of disinfectant solutions in hospitals and clinics generally protects against contamination and lowers risk of acquiring HAIs. They can also be used to eliminate bacteria and microbes before they can enter a patient’s body. Such solutions are required in hospitals to maintain proper hygiene and sanitation, thereby lowering the risk of HAIs, which is anticipated to propel market growth over the forecast period.

Access Research Report of Antiseptics And Disinfectants Market https://www.grandviewresearch.com/industry-analysis/antiseptics-and-disinfectants-market

Antiseptics And Disinfectants Market Report Highlights

  • In terms of revenue, the quaternary ammonium compounds segment held the largest revenue share in 2020 owing to rising incidence of healthcare-associated infections and increasing number of hospitals across the globe
  • The enzymatic cleaners segment is expected to witness the fastest growth over the forecast period. The growth of this segment can be attributed to the increasing number of hospitals in developing countries
  • The hospital segment is expected to witness the fastest growth rate over the forecast period. Increasing number of hospitals in developing countries is expected to propel segment growth
  • The B2B held the largest revenue share in 2020 owing to the rising end users opting for this sales channel across the globe
  • In Asia Pacific, the market is expected to witness the fastest growth over the forecast period owing to the rising prevalence of cardiovascular, neurology, and urology disorders

List of Key Players of Antiseptics And Disinfectants Market

  • 3M
  • Reckitt Benckiser
  • STERIS plc
  • Kimberly-Clark Corporation
  • Bio-Cide International
  • Cardinal Health
  • BD
  • Johnson & Johnson

Access Press Release of Antiseptics And Disinfectants Market @ https://www.grandviewresearch.com/press-release/global-antiseptics-disinfectants-market

 

]]>
Oral Care Market Detailed Analysis By Product, Product Type, Application, Region And Forecast To 2028 Tue, 02 Mar 2021 09:02:27 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692635.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692635.html Grand View Research Grand View Research San Francisco, 2 March 2021: The Report Oral Care Market Size, Share & Trends Analysis Report By Product (Toothbrush, Toothpaste), By Product Type (Countertop, Cordless), By Application (Home, Dentistry), By Region, And Segment Forecasts, 2021 - 2028

The global oral care market size is expected to reach USD 49.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.9% from 2021 to 2028. The growing awareness among people regarding oral hygiene and the increasing incidence of dental caries has led to the high growth of the market. The World Health Organization (WHO) states that 2.3 billion people suffer from caries of permanent teeth. An unhealthy diet (particularly high in sugar) is one of the major factors contributing to the rise in the number of dental caries at the global level. Brushing teeth using a toothbrush and fluoride-containing toothpaste can prevent dental caries to a significant extent, creating demand for these products.          

Various awareness programs initiated by major players have led to increased awareness about dental hygiene among the people of both developed as well as developing regions. For instance, Colgate-Palmolive Company’s BRIGHT SMILES, BRIGHT FUTURES program has been proactively involved in spreading oral health education and providing dental screenings, and over one billion children and their families in 80 countries benefited from it. In 2018-19 alone, it reached over 11.5 million children in India. Thus, such initiatives have played a key role in creating awareness among consumers at the global level about the importance of dental hygiene.

New product development is another significant factor influencing the demand for the products. Innovative products such as powered toothbrushes have revolutionized the toothbrush market. In November 2019, a leading player, Procter & Gamble launched "Tooth Fairy in a Box.” It includes an Oral-B electric toothbrush, Crest toothpaste, and playful items that help parents encourage children to embrace dental hygiene. The availability of different denture care products and dental accessories is also contributing to the growth of the market.

Most of the dental services were shut down at the global level during the COVID-19 pandemic. Recently, more number of dental practices are reopening, however, consumers are opting for home dental remedies due to potential risk. Leading personal care companies such as Procter & Gamble; Colgate-Palmolive Company; and Johnson & Johnson Services, Inc. witnessed growth in their sales, especially from the oral care segment as consumers’ focus toward hygiene grew.

Access Research Report of Oral Care Market https://www.grandviewresearch.com/industry-analysis/oral-care-market

Oral Care Market Report Highlights

  • By product, the toothbrush segment dominated the market in 2020 and is expected to emerge as the fastest-growing segment during the forecast period due to the availability of a wide range of innovative designs, such as electric and battery-powered toothbrushes
  • The toothpaste product segment held the second-largest share in 2020 due to the increase in the number of people using different forms of toothpaste
  • Asia Pacific held the largest share in 2020 and is projected to be the fastest-growing regional market during the forecast period. This is due to the rising awareness about oral health among the people of developing countries, such as India and China
  • Manufacturers coming up with innovative and easy-to-use oral care products has increased the usage of these products at home, making home the largest and fastest-growing segment

List of Key Players of Oral Care Market

  • Procter & Gamble Company
  • Johnson & Johnson Services, Inc.
  • Colgate-Palmolive Company
  • GlaxoSmithKline plc
  • Church & Dwight Co., Inc.
  • Fresh, LLC
  • Dentaid
  • Lion Corporation
  • Sunstar Suisse S.A.

Access Press Release of Oral Care Market @ https://www.grandviewresearch.com/press-release/global-oral-care-market

 

]]>
Personal Mobility Devices Market Overview By Product ,Region And Forecast To 2028 Tue, 02 Mar 2021 08:44:48 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692630.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692630.html Grand View Research Grand View Research San Francisco, 2 March 2021: The Report Personal Mobility Devices Market Size, Share, & Trends Analysis Report By Product (Walking Aids, Wheelchairs, Scooters), By Region (Europe, APAC, North America, MEA), And Segment Forecasts, 2021 - 2028

The global personal mobility devices market size is expected to reach USD 18.2 billion by 2028 registering a CAGR of 5.8% over the forecast period, according to a new report by Grand View Research, Inc. Growing R&D investments for new product development and government initiatives aimed at strengthening reimbursement frameworks are some of the key factors propelling the market growth. The rising geriatric population and prevalence of target diseases, such as arthritis, Parkinson’s, and Alzheimer’s, are also expected to drive the market over the forecast period.

According to a report published by the WHO in 2020, the number of people aged 60 years and above is likely to grow by 56.0%, from 962 million in 2017 to 1.4 billion in 2030, thus showcasing the probable addressable market. Furthermore, the rising number of surgical procedures, due to growing cases of neurological & cardiovascular disorders and an increasing number of accidents and trauma cases, is contributing towards the market growth. Europe was the most matured regional market in 2020 and accounted for the largest revenue share of over 33%.

The regional market will retain its leading position throughout the forecast years. Sophisticated healthcare infrastructure and growing healthcare expenditure are some of the factors contributing to its large share. Asia Pacific is expected to register the fastest CAGR during the forecast period due to the rising demand for personal mobility devices as a result of the growing geriatric population and increasing disposable income & awareness levels. However, decreased production of these devices due to the Covid-19 pandemic has severely affected the industry growth. The prices of wheelchairs and scooters have also dropped extremely.

Access Research Report of Personal Mobility Devices Market https://www.grandviewresearch.com/industry-analysis/personal-mobility-devices-market

Personal Mobility Devices Market Report Highlights

  • Wheelchairs was the largest product segment in 2020 owing to an increase in demand for powered wheelchairs, especially in developed countries, such as U.S. and Germany
  • Europe dominated the global market in 2020 due to increased healthcare expenditure and geriatric population in the region
  • The Asia Pacific is expected to be the fastest-growing regional market during the forecast period owing to the rising geriatric population and increasing disposable income levels
  • Major market players are adopting various strategies to gain a competitive edge over others
  • Some of these strategies include strategic alliances with buyers and the development of advanced devices via extensive R&D investments

List of Key Players of Personal Mobility Devices Market

  • Drive DeVilbiss Healthcare
  • GF Health Products, Inc.
  • Invacare Corporation
  • Carex Health Brands, Inc.
  • Kaye Products, Inc.
  • Briggs Healthcare
  • Medline Industries, Inc.
  • NOVA Medical Products
  • Performance Health
  • Rollz International

Access Press Release of Personal Mobility Devices Market @ https://www.grandviewresearch.com/press-release/global-personal-mobility-devices-market

 

]]>
Aesthetic Medicine Market Scope By Procedure Type ,Region And Forecast To 2028 Tue, 02 Mar 2021 08:32:19 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692627.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692627.html Grand View Research Grand View Research 1080x630_Aesthetic Medicine Market_Vishal_Pradnya_January

San Francisco, 2 March 2021: The Report Aesthetic Medicine Market Size, Share & Trends Analysis Report By Procedure Type (Invasive Procedures, Non-invasive Procedures), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2021 - 2028

The global aesthetic medicine market size is expected to reach USD 124.7 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.8% from 2021 to 2028. According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is ‘a branch of medicine focused on satisfying the aesthetic desires and goals of patient. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Key drivers of the market include introduction of non-invasive medical devices for cosmetic procedures, growing focus on physical appearance, and rise in adoption among geriatric individuals.

Based on procedure type, the market is mainly divided into invasive and non-invasive procedures. Invasive procedures include breast augmentation, liposuction, and nose reshaping while non-invasive procedures include popular technology such as Botox injections, soft tissue fillers, and chemical peel. Rise in number of obesity cases in the U.S. has urged patients to opt for cosmetic treatments in the country.

In Asia Pacific, rise in income level of the adult population in countries such as China and India is expected to create lucrative opportunity for the market. The region is also backed by South Korea, which is the hub of cosmetic surgeries.

Access Research Report of Aesthetic Medicine Market https://www.grandviewresearch.com/industry-analysis/medical-aesthetics-market

Aesthetic Medicine Market Report Highlights

  • The non-invasive procedures segment is projected to dominate throughout the forecast period owing to its quicker and accurate results along with ease of usage compared to invasive procedures
  • Breast augmentation and liposuction are among the fastest growing under the invasive procedures segment in the forecast years
  • In Asia Pacific, the market is projected to witness a CAGR of 10.9% during the forecast period. Countries such as South Korea and India are expected to serve as key revenue pockets

List of Key Players of Aesthetic Medicine Market

  • Allergan Inc.
  • Hologic (cynosure)
  • Johnson & Johnson
  • Galderma
  • Lumenis
  • Solta Medical
  • Syneron Candela
  • Alma Laser

Access Press Release of Aesthetic Medicine Market @ https://www.grandviewresearch.com/press-release/global-aesthetic-medicine-market

 

 

 

]]>
Medical Device Outsourcing Market Latest Report By Service, Application, Region And Forecast To 2028 Tue, 02 Mar 2021 08:01:42 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692618.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692618.html Grand View Research Grand View Research San Francisco, 2 March 2021: The Report Medical Device Outsourcing Market Size, Share & Trends Analysis Report By Service (Quality Assurance, Contract Manufacturing), By Application (Cardiology, General & Plastic Surgery), And Segment Forecasts, 2021 - 2028

The global medical device outsourcing market size is expected to reach USD 227.1 billion by 2028 registering a CAGR of 11.2%, according to a new report by Grand View Research, Inc. Rising demand for advanced medical products is the key factor fueling the market growth. Regulatory bodies are emphasizing the quality of the healthcare devices provided to the public. Thus, to meet the regulatory standards, market players are using various services like regulatory consulting. For example, the European Medical Device Regulation undertakes special spontaneous inspection of outsourced products to test the quality as well as conformity with the standards.

Contract manufacturers in developed countries like the EU nations comply with the international standards for a quality management system, which makes them a preferred option as compared to the ones in developing countries like India and China. However, the regulatory changes anticipated in the developing countries ensure compliance by contract manufacturers. Demand for regulatory compliance is expected to boost the growth of consulting services, such as remediation, compliance, and QMS, thereby contributing to the growth of the global market.

However, the current pandemic has put the MedTech industry at the center stage with unmatched demand for PPE, diagnostic tests, ventilators, and other critical supplies. Besides the ongoing extraordinary measures to promptly ramp up the manufacturing capacity & capabilities, Medtech leaders are seeking outside their boundaries of the normal sector to explore innovative solutions to supplement the capacity, such as open-source equipment design, as well as partnerships with firms outside the sector.

Access Research Report of Medical Device Outsourcing Market https://www.grandviewresearch.com/industry-analysis/medical-device-outsourcing-market

Medical Device Outsourcing Market Report Highlights

  • The contract manufacturing segment led the market in 2020 with a revenue share of 55.4% and will retain its position throughout the forecast period
  • This growth is due to the increasing trend of outsourcing by OEMs to third-party manufacturers, especially in emerging countries
  • The quality assurance services segment is projected to exhibit the fastest CAGR over the forecast period
  • Asia Pacific was the dominant regional market in 2020 owing to the easy availability of skilled human resources

List of Key Players of Medical Device Outsourcing Market

  • SGS SA
  • IQVIA
  • Toxikon, Inc.
  • Eurofins Scientific SE
  • Pace Analytical Services, Inc.
  • Intertek Group plc
  • WuXi AppTec, Inc.
  • North American Science Associates, Inc.
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corp.

Access Press Release of Medical Device Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-medical-device-outsourcing-market

]]>
Dental Implant Market Latest Trends On The Basis Of Implant Type ,Region And Forecast To 2028 Tue, 02 Mar 2021 07:32:20 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692606.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692606.html Grand View Research Grand View Research San Francisco, 2 March 2021: The Report Dental Implant Market Size, Share & Trends Analysis Report By Implants Type (Titanium, Zirconium), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2021 - 2028

The global dental implant market size is expected to reach USD 8.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.0% from 2021 to 2028. Rising demand for tooth replacement has provided good growth potential to the market. The increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting market growth.

With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry data, more than 95.0% of individuals across the globe believe that their smile is a vital social asset and nearly 84.0% revealed to be under an increased pressure to perfect their smile, thus increasing the product demand. Dental implants are considered the only restorative technique that preserves and stimulates natural bone. Owing to the growing number of edentulous people, the demand for prosthetics is increasing, which is expected to be one of the major impact rendering drivers for the market.

Several industries have halted their services due to the COVID-19 pandemic. However, the dental care industry is greatly impacted by the significant decrease in elective procedures, many of which are being postponed or canceled so that hospitals can focus their resources on treating patients with COVID-19. Major Countries like the U.S and India procure raw materials and electronic components from China, which has disrupted the supply chain of much dental equipment and product manufacturers. However, with the decrease in the number of COVID-19 cases, hospitals are likely to begin scheduling elective procedures, depending on their capacity of admission and patients comfort level.

Access Research Report of Dental Implant Market https://www.grandviewresearch.com/industry-analysis/dental-implants-market

Dental Implant Market Report Highlights

  • The titanium implant type segment held the largest market share in 2020 due to its wide applications, durability, and cost-effectiveness
  • Zirconia implants are anticipated to witness a lucrative growth rate over the forecast period due to better flexural strength, improved aesthetic appearance, and less corrosiveness as compared to titanium
  • North America dominated the market in 2020 owing to high awareness about restorative treatments and the presence of established market players

List of Key Players of Dental Implant Market

  • BioHorizons IPH, Inc.
  • Nobel Biocare Services AG
  • Zimmer Biomet Holdings, Inc.
  • OSSTEM IMPLANT
  • Institut Straumann AG
  • Bicon, LLC
  • Leader Italy
  • Anthogyr SAS
  • DENTIS
  • DENTSPLY Sirona
  • DENTIUM Co., Ltd.
  • T-Plus Implant Tech. Co.
  • KYOCERA Medical Corporation

Access Press Release of Dental Implant Market @ https://www.grandviewresearch.com/press-release/global-dental-implants-market

 

]]>
Clinical Laboratory Service Market Overview By Test Type, Service Provider, Application, Region And Forecast Till 2028 Tue, 02 Mar 2021 07:13:43 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692600.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692600.html Grand View Research Grand View Research San Francisco, 2 March 2021: The Report Clinical Laboratory Service Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology), By Service Provider, By Application, By Region, And Segment Forecasts, 2021 - 2028

The global clinical laboratory service market size is expected to reach USD 288.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2021 to 2028. Growing prevalence of target diseases such as diabetes and cardiovascular diseases is expected to positively impact the market growth over the forecast period. For instance, according to the WHO, by 2030, cardiovascular diseases are estimated to cause approximately 23.6 million deaths, mainly from heart disease and stroke.

The COVID-19 pandemic, caused due to SARS-CoV-2, is affecting millions of people globally. According to WHO and CDC, the standard for laboratory diagnosis of COVID-19 is Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for samples collected from the respiratory tract. The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure are driving the market.

Furthermore, in May 2020, the Department of Health and Human Services (HHS) provided more than USD 200 million to clinics in rural areas of the U.S. to expedite COVID-19 testing. Such robust investments by government bodies to increase adoption of COVID-19 diagnostic kits by clinics are anticipated to boost segment growth. COVID-19 walk-up clinics in San Jose are another key initiative expected to positively impact segment growth.

In addition, advancements in laboratory testing technology through incremental and breakthrough developments are expected to serve this market as a high impact rendering driver. For instance, in March 2020, a Singapore-based med-tech company, Biolidics, launched a rapid test kit for COVID-19 and entered into a manufacturing agreement with a diagnostic kit manufacturer for mass production.

Automation in clinical settings has significantly improved the data management process in labs. Improving adoption rates of laboratory automation systems is expected to boost the market throughout the forecast period. Furthermore, database management tools, patient test records, and integrated workflow management systems have received significant consideration in the healthcare industry.

Access Research Report of Clinical Laboratory Service Market https://www.grandviewresearch.com/industry-analysis/clinical-laboratory-services-market

Clinical Laboratory Service Market Report Highlights

  • In 2020, the clinical chemistry segment held majority of revenue share owing to presence of large number of tests due to increasing knowledge on clinical chemistry
  • Stand-alone laboratories is expected to witness lucrative growth rate over the forecast period due to introduction of digital support systems to manage large databases and ability to provide better clinical laboratory services at a comparatively lower rate
  • The bioanalytical and lab chemistry services segment dominated the market in 2020 owing to rising use of wide range of techniques and technology platforms to fulfill diagnostic needs
  • In Asia Pacific, the market is projected to witness the fastest growth over the forecast period owing to a growing awareness, increased government initiatives, and positive regulatory policies
  • North America dominated the market in 2020 due to technological advancements and high awareness on medical standards

List of Key Players of Clinical Laboratory Service Market

  • Qiagen
  • OPKO Health, Inc.
  • Charles River Laboratories
  • International, Inc
  • Sonic Healthcare
  • Almac Group
  • Laboratory Corporation of America Holdings (LabCorp)
  • DaVita, Inc.
  • Viapath Group LLP
  • Abbott
  • SGS SA
  • Quest Diagnostics, Inc.
  • NeoGenomics Laboratories, Inc.
  • Siemens Healthcare GmbH
  • Fresenius Medical Care
  • Cinven
  • Arup Laboratories

Access Press Release of Clinical Laboratory Service Market @ https://www.grandviewresearch.com/press-release/global-clinical-laboratory-services-market

 

]]>
Active Pharmaceutical Ingredients Market Overview By Type Of Synthesis, Type Of Manufacturer, Type, Application, Region And Forecast To 2028 Mon, 01 Mar 2021 13:05:10 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692417.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692417.html Grand View Research Grand View Research Active-Pharmaceutical-Ingredients

San Francisco, 17 Feb 2021: The Report Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2021 - 2028

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like “Make in India”.

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Access Research Report of Active Pharmaceutical Ingredients Market https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

Active Pharmaceutical Ingredient Market Report Highlights

  • According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
  • The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
  • According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
  • Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
  • Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

List of Key Players of Active Pharmaceutical Ingredient Market

  • Merck & Co., Inc.
  • AbbVie, Inc.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Cipla, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Albemarle Corporation
  • Viatris Inc.
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Reddy’s Laboratories Ltd.

Access Press Release of Active Pharmaceutical Ingredients Market @ https://www.grandviewresearch.com/press-release/global-active-pharmaceutical-ingredients-api-market

 

]]>
Pharmacy Automation Devices Market Scope By Product, End-Use, Region And Forecast To 2028 Mon, 01 Mar 2021 12:23:43 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692401.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692401.html Grand View Research Grand View Research San Francisco, 1 March 2021: The Report Pharmacy Automation Devices Market Size, Share & Trends Analysis Report By Product (Medication Dispensing Systems, Automated Medication Compounding Systems), By End Use, And Segment Forecasts, 2021 - 2028

The global pharmacy automation devices market size is expected to reach USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.3% from 2021 to 2028. The increasing burden of chronic diseases and the growing geriatric population are leading to an increase in the number of prescriptions. This, in turn, is resulting in a rise in the number of medication errors. For instance, 237.4 million medication errors occurred in England in 2018, according to the article published in The Pharmaceutical Journal. This is driving the demand for pharmacy automation devices. Moreover, an increase in initiatives by various organizations, such as the American Society of Health-System Pharmacists, to reduce medication errors is positively impacting the market growth.

In 2020, the medication dispensing systems product segment accounted for the largest revenue share owing to the benefits offered by these products, such as minimized medication errors, better inventory management, improved medication adherence for patients with complex treatments, improved patient care, minimized drug waste with true split-fills, improved storage capacity, and reduced administrative burden among the end-users. The automated medication compounding systems segment is anticipated to witness the fastest growth during the forecast period. Reduction in compounding errors and contamination is a major factor driving the segment. Moreover, the increasing adoption of these devices for sterile compounding is fueling the segment growth.

The retail pharmacy end-use segment accounted for the largest revenue share in 2020. The rising adoption of these solutions, the presence of a large number of retail pharmacies, and growing investments in this sector are driving the segment. For instance, in May 2018, McKesson Co., a Healthcare Information Technology (HIT) company, entered into an agreement with Discount Drug Mart, which is an Ohio-based retail drug store, to build an automated central fill pharmacy. The hospital pharmacy is anticipated to witness the fastest growth during the forecast period owing to the adoption of automated technologies by hospitals. For instance, in February 2020, Geisinger, a health provider in the U.S., partnered with Omnicell, Inc. for the implementation of an automated dispensing system.

In 2020, North America dominated the market. This is attributed to the presence of a large number of industry players, such as BD, Omnicell, Baxter, AmerisourceBergen, and Cerner. The majority of the companies such as BD and Baxter generated more than 50% of sales revenue in the U.S. Asia Pacific is anticipated to witness the fastest growth during the forecast period. Rapid adoption in automated solutions, investments in the adoption of healthcare IT infrastructure, and high healthcare spending are the key factors contributing to the growth of the market. Moreover, initiatives by public and private bodies to reduce medication errors are likely to drive the regional market.

Access Research Report of Pharmacy Automation Devices Market https://www.grandviewresearch.com/industry-analysis/pharmacy-automation-market

Pharmacy Automation Devices Market Report Highlights

  • The market is driven by various technological advancements and increasing investments in the automation sector
  • Based on product, the medication dispensing systems segment dominated the market in 2020 owing to the increasing adoption of these products to avoid errors while dispensing medication
  • By end-use, the retail pharmacy segment dominated the market in 2020 owing to high adoption rates of these devices and investments by major retail chains, such as CVS Health and Walgreens
  • North America dominated the market in 2020 owing to the presence of a large number of automation companies in the region

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research, Inc. has segmented the global pharmacy automation devices market on the basis of product, end-use, and region:

Pharmacy Automation Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Medication Dispensing Systems
  • Packaging and Labeling Systems
  • Storage and Retrieval Systems
  • Automated Medication Compounding Systems
  • Tabletop Tablet Counters

Pharmacy Automation Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospital Pharmacy
  • Retail Pharmacy

Pharmacy Automation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • K.
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Singapore
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Pharmacy Automation Devices Market

  • Amerisource Bergen Corporation
  • Accu Chart Plus Healthcare Systems, Inc.
  • Omnicell, Inc.
  • McKesson Corporation
  • Pearson Medical Technologies, LLC
  • Baxter
  • Talyst, LLC
  • ScriptPro, LLC
  • CareFusion (Becton Dickinson And Company)
  • Medacist Solutions Group, LLC
  • Kirby Lester
  • Cerner Corporation
  • iA
  • ARxIUM
  • TouchPoint Medical
  • Deenova S.R.L
  • Parata Systems, LLC
  • Swisslog Healthcare
  • Yuyama Co. Ltd.

Access Press Release of Pharmacy Automation Devices Market @ https://www.grandviewresearch.com/press-release/global-pharmacy-automation-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

]]>
Hemoglobinopathies Market Latest Trends On The Basis Type, Diagnosis, Therapy, Region And Forecast To 2028 Mon, 01 Mar 2021 12:04:49 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692392.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692392.html Grand View Research Grand View Research San Francisco, 1 March 2021: The Report Hemoglobinopathies Market Size, Share & Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease, Other Hemoglobin (Hb) Variants), By Diagnosis, By Therapy, By Region, And Segment Forecasts, 2021 - 2028

The global hemoglobinopathies market size is expected to reach USD 15.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.8% from 2021 to 2028. Increasing awareness regarding hemoglobinopathies and government initiatives to diagnose the diseases at an early stage are expected to propel the market growth over the forecast period. Moreover, increasing R&D investment, the presence of a promising drug pipeline, and technologically advanced diagnostics platforms are expected to boost the growth of the market.

The development of novel curative technologies, such as CRISPR/Cas9 and hematopoietic stem cell transplantation, coupled with a promising pipeline, is expected to propel market growth. Moreover, the presence of regulatory agencies, such as the FDA, which are working toward improving drug approval rate by granting accelerated approval for hemoglobinopathies drugs, is expected to drive the market. For instance, in 2019, the FDA has approved four novel drugs: Reblozyl by Bristol-Myers Squibb Company, Adakveo by Novartis AG, Zynteglo by bluebird bio, Inc., and Oxbryta by Global Blood Therapeutics, Inc. for the treatment of hemoglobinopathies.

Initiatives such as the Sickle Cell Awareness Initiative (SCAI) are working toward educating the people about the disease, which will increase the diagnosis and treatment rate. SCAI also raises funds for individuals affected with sickle cell diseases (SCDs) and provides research funding. Moreover, governments of Middle Eastern and Asian countries provide funds for R&D of hemoglobinopathies treatment. For instance, various programs undertaken by governments, such as thalassemia screening in neonates and providing medicines, are impacting the market growth positively.

The high patient population in low-income countries has encouraged market players and non-profit organizations to launch several initiatives to improve the access to the therapy. For instance, in February 2019, the Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) was launched by Global Blood Therapeutics, Inc. in order to provide research funding for novel SCD projects, with an aim to expand the access to optimal healthcare for sickle cell disease.

Biopharmaceutical companies are collaborating with nonprofit organizations to promote public awareness about hemoglobinopathies. For instance, in June 2018, the Sickle Cell Disease Association of America partnered with Emmaus Life Sciences, Inc. to provide online educational tools to sickle cell patients, friends, clinicians, caregivers, and researchers for spreading awareness about complications associated with SCD.

An increase in investment and funding for the development of novel therapies to treat hemoglobinopathies will further boost the market growth over the forecast period. The National Heart, Lung, and Blood Institute (NHLBI) has significantly invested in research & development in sickle cell disease. The NHLBI supports research work through various initiatives. Furthermore, private funding such as the Bronx Blood Research Fund (BBRF) provides a platform for research and management of thalassemia and other hemoglobinopathies.

Gene therapy has emerged as a promising treatment option for managing hemoglobin disorder as it targets the underlying genetic cause of the condition through the administration of one-time gene therapy and significantly reduces the need for blood transfusions. The current pipeline of gene therapy products includes CTX001 (CRISPR Therapeutics), BIVV003 (Sangamo Therapeutics, Inc. & Bioverativ Inc), and HGB-206 (bluebird bio, Inc).

Access Research Report of Hemoglobinopathies Market https://www.grandviewresearch.com/industry-analysis/hemoglobinopathies-market

Hemoglobinopathies Market Report Highlights

  • Based on type, sickle cell disease accounted for the largest share of 56.6% in 2020 and is anticipated to maintain its lead over the forecast period
  • The newborn patient population with sickle cell anemia is anticipated to reach 400,000 by 2050. Half of the global sickle cell anemia burden is present in India, Nigeria, and the Democratic Republic of the Congo
  • By therapy, in the thalassemia segment, the blood transfusion segment held the largest market share in 2020 and is estimated to dominate the market throughout the forecast period
  • Asia Pacific is expected to witness the fastest growth over the forecast period owing to a large potential patient base and high unmet medical needs in the region
  • North America held the largest market share in 2020 due to government initiatives focusing on the development of new therapies and better reimbursement scenario

List of Key Players of Hemoglobinopathies Market

  • Sangamo Therapeutics, Inc.
  • Global Blood Therapeutics, Inc.
  • bluebird bio, Inc.
  • Emmaus Life Sciences Inc.
  • Pfizer, Inc.
  • Novartis AG
  • Prolong Pharmaceuticals, LLC
  • Bioverativ Inc.
  • Gamida Cell

Access Press Release of Hemoglobinopathies Market @ https://www.grandviewresearch.com/press-release/global-hemoglobinopathies-market

 

]]>
Ceramic And Natural Stone Tiles Market Overview By Product ,Region And Forecast Till 2028 Mon, 01 Mar 2021 11:35:58 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/692384.html http://comunicati.net/comunicati/aziende/informatica/information_technology/692384.html Grand View Research Grand View Research San Francisco, 1 March 2021: The Report Ceramic And Natural Stone Tiles Market Size, Share & Trends Analysis Report By Product (Granite, Limestone, Travertine, Porcelain Tiles), By Region (North America, APAC, Europe), And Segment Forecasts, 2021 - 2028

The global ceramic and natural stone tiles market size is expected to reach USD 567.61 billion by 2028 growing at a CAGR of 5.8% over the forecast period, according to a new report by Grand View Research, Inc. Easy installation and availability in a wide range of options in terms of color and dimensions are projected to augment the product demand over the forecast period.

A positive outlook of the construction industry on accounts of rising residential and non-residential building construction activities is expected to favor the market growth. Moreover, growing consumer preference for these products in flooring, decorative wall, and various internal & external applications supported by the rising demand for low-maintenance construction materials is projected to augment the market growth. Rapid urbanization coupled with an evolving consumer lifestyle is also expected to generate new growth prospects for the companies in this industry.

Stringent environment regulations have led to an increase in R&D activities and the development of eco-friendly products, which is also expected to boost the market growth in the years to come. In addition, an initiative taken by the Government of Italy to promote the ceramic industry is expected to offer several growth opportunities over the forecast years.

Access Research Report of Ceramic And Natural Stone Tiles Market https://www.grandviewresearch.com/industry-analysis/ceramic-and-natural-stone-tiles-market

Ceramic And Natural Stone Tiles Market Report Highlights

  • The porcelain product segment accounted for more than 51% of the total market share in 2020 and is projected to grow at the fastest CAGR of 6.3% from 2021 to 2028
  • This growth is credited to the rising product demand on account of its properties, such as easy maintenance and chemical & stain resistance are expected to fuel the segment growth
  • The glazed ceramic product segment accounted for the second-largest market share in 2020 and is expected to have significant CAGR over the forecast period
  • This growth is mainly due to the increasing product demand in applications, such as kitchens and bathrooms
  • The Europe regional market accounted for the second-highest revenue share in 2020 and is projected to grow at a steady CAGR of 5.2% from 2021 to 2028 due to the increased penetration of the product in the region’s construction industry
  • Asia Pacific is estimated to be the largest as well as the fastest-growing regional market from 2021 to 2028
  • The region’s growth is attributed to the rising number of construction activities and rapid infrastructural development in emerging countries like India and China
  • China accounted for the significant market share of the APAC regional market on account of the growing population and rapidly expanding residential and commercial sector in the country

List of Key Players of Ceramic And Natural Stone Tiles Market

  • Porcelanosa Grupo
  • Grupo Cedasa
  • Crossville, Inc.
  • Atlas Concorde
  • Mohawk Industries

Access Press Release of Ceramic And Natural Stone Tiles Market @ https://www.grandviewresearch.com/press-release/global-ceramic-natural-stone-tiles-market

 

]]>